Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Fresenius Medical Care reserves €200 million in FCPA case

Jaclyn Jaeger | February 27, 2018

Germany-based Fresenius Medical Care, a provider of dialysis products and services, disclosed this week that it has set aside €200 million concerning its ongoing settlement negotiations with the U.S. government regarding potential violations of the Foreign Corrupt Practices Act.

The provision concerns recent developments in the ongoing settlement negotiations with the U.S. Department of Justice and the U.S. Securities Exchange Commission. “The provision represents an estimate from a range of potential outcomes: The charge encompasses government agencies’ claims for profit disgorgement, as well as accruals for fines and/or penalties, certain legal and other consultancy expenses, and other related costs or asset impairments,” the company stated.

In 2012, Fresenius Medical Care said it...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.